Tanja Schroeder

Tanja Schroeder

Auto-generated profile, based on publicly available information

Tanja Schroeder

Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in JMIR Aging
Verified
Journal Article
Open access
TSTanja Schroeder
Tanja Schroeder
LDLaura Dodds
Laura Dodds
AGAndrew Georgiou
Andrew Georgiou
HGHeiko Gewald
Heiko Gewald
JSJoyce Siette
Joyce Siette
Background: Ongoing advancements in digital solutions support older adults’ healthy aging and well-being. However, a unified synthesis of sociodemographic, cognitive, attitudinal, emotional, and environmental factors that influence older adults’ intention to use these new digital technologies is still lacking. Understanding the salient factors that influence older adults’ intention to use digital technologies will help to ensure that technology is developed appropriately and contextually. This understanding is also likely to contribute to developing technology acceptance models specifically for the aging generation, by reorganizing principles and constructing objectivity criteria for future research studies. Objective: This review aims to identify the key factors associated with older adults’ intention to use digital technologies and to provide a comprehensive conceptual framework to describe the relationships between these key factors and older adults’ intention to use digital technologies. Methods: A mapping review was conducted using 9 databases from inception to November 2022. Articles were selected for review if they had an evaluative component of older adults’ intention to use digital technologies. Three researchers independently reviewed the articles and extracted the data. Data synthesis was performed via narrative review and quality appraisal was measured using 3 different tools based on each article’s study design. Results: We identified a total of 59 articles investigating older adults’ intention to use digital technologies. The majority (40/59, 68%) of articles did not use an existing framework or model for technology acceptance. Studies mostly adopted a quantitative research design (27/59, 46%). We found 119 unique factors reported to influence older adults’ intention to use digital technologies. These were categorized into 6 distinct themes: Demographics and Health Status, Emotional Awareness and Needs, Knowledge and Perception, Motivation, Social Influencers, and Technology Functional Features. Conclusions: Given the importance of global demographic change toward an aging society, there is surprisingly limited research on the factors that influence older adults’ intention to use digital technologies. Our identification of the key factors across different types of digital technology and models supports the future integration of a comprehensive perspective encompassing environmental, psychological, and social determinants for older adults’ intention to use digital technologies.

13 June 2022 in JMIR Formative Research
Verified
Journal Article
Open access
TSTanja Schroeder
Tanja Schroeder
MHMaximilian Haug
Maximilian Haug
HGHeiko Gewald
Heiko Gewald
Background: New technologies such as mobile health (mHealth) apps and smart speakers make intensive use of sensitive personal data. Users are typically aware of this and express concerns about their data privacy. However, many people use these technologies although they think their data are not well protected. This raises specific concerns for sensitive health data. Objective: This study aimed to contribute to a better understanding of data privacy concerns of mature adults using new technologies and provide insights into their data privacy expectations and associated risks and the corresponding actions of users in 2 different data contexts: mHealth apps and smart speakers. Methods: This exploratory research adopted a qualitative approach, engaging with 20 mature adults (aged >45 years). In a 6-month test period, 10 (50%) participants used a smart speaker and 10 (50%) participants used an mHealth app. In interviews conducted before and after the test period, we assessed the influence of data privacy concerns on technology acceptance, use behavior, and continued use intention. Results: Our results show that although participants are generally aware of the need to protect their data privacy, they accept the risk of misuse of their private data when using the technology. Surprisingly, the most frequently stated risk was not the misuse of personal health data but the fear of receiving more personalized advertisements. Similarly, surprisingly, our results indicate that participants value recorded verbal data higher than personal health data. Conclusions: Older adults are initially concerned about risks to their data privacy associated with using data-intensive technologies, but those concerns diminish fairly quickly, culminating in resignation. We find that participants do not differentiate between risky behaviors, depending on the type of private data used by different technologies.

12 February 2025 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SSSamran Sheriff
Samran Sheriff
MSMaree Saba
Maree Saba
RPRomika Patel
Romika Patel
GFGeorgia Fisher
Georgia Fisher
TSTanja Schroeder
Tanja Schroeder
LELouise Ann Ellis
Louise Ann Ellis
Background: Liquid biopsy (LB) offers a promising, minimally invasive alternative to traditional tissue biopsies in cancer care, enabling real-time monitoring and personalized treatment. Despite its potential, the routine implementation of LB in clinical practice faces significant challenges. This scoping review examines the barriers and facilitators influencing the implementation of liquid biopsies into standard cancer care. Methods: Four academic databases (PubMed, Scopus, Embase, and Web of Science) were systematically searched without language restrictions. We included peer-reviewed articles that were published between January 2019 and March 2024 that focused on the implementation of LB in cancer care or described barriers and facilitators to its implementation. Data relevant to the review objective, including key article characteristics; barriers and facilitators of implementation; and recommendations for advancement or optimisation; were extracted and analysed using thematic and visual network analyses. Results: The majority of the included articles were narrative review articles (84%), with most from China (24.2%) and the United States (20%). Thematic analysis identified four main categories and their associated barriers and facilitators to the implementation of LB in cancer care: (1) Laboratory and personnel requirements; (2) Disease specificity; (3) Biomarker-based liquid biopsy; and (4) Policy and regulation. The majority of barriers identified were concentrated in the pre-analytical phase, highlighting the lack of standardization in LB technologies and outcomes. Conclusions: Through a thematic analysis of the barriers and facilitators to LB implementation, we present an integrated tool designed to encourage the standardization of testing methods for clinical practice guidelines in the field.

17 January 2024 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
TSTanja Schroeder
Tanja Schroeder
MHMaximilian Haug
Maximilian Haug
AGAndrew Georgiou
Andrew Georgiou
KSKarla Seaman
Karla Seaman
HGHeiko Gewald
Heiko Gewald
Background: The enactment of the “Act to Improve Healthcare Provision through Digitalisation and Innovation ” (Digital Healthcare Act; Digitale-Versorgung-Gesetz [DVG]) in Germany has introduced a paradigm shift in medical practice, allowing physicians to prescribe mobile health (mHealth) apps alongside traditional medications. This transformation imposes a dual responsibility on physicians to acquaint themselves with qualifying apps and align them with patient diagnoses, while requiring patients to adhere to the prescribed app use, similar to pharmaceutical adherence. This transition, particularly challenging for older generations who are less skilled with technology, underscores a significant evolution in Germany’s medical landscape. Objective: This study aims to investigate physicians’ responses to this novel treatment option, their strategies for adapting to this form of prescription, and the willingness of patients to adhere to prescribed mHealth apps. Methods: Using an exploratory qualitative study design, we conducted semistructured interviews with 28 physicians and 30 potential patients aged 50 years and older from August 2020 to June 2021. Results: The findings reveal several factors influencing the adoption of mHealth apps, prompting a nuanced understanding of adoption research. Notably, both physicians and patients demonstrated a lack of information regarding mHealth apps and their positive health impacts, contributing to a deficiency in trust. Physicians’ self-perceived digital competence and their evaluation of patients’ digital proficiency emerge as pivotal factors influencing the prescription of mHealth apps. Conclusions: Our study provides comprehensive insights into the prescription process and the fundamental factors shaping the adoption of mHealth apps in Germany. The identified information gaps on both the physicians’ and patients’ sides contribute to a trust deficit and hindered digital competence. This research advances the understanding of adoption dynamics regarding digital health technologies and highlights crucial considerations for the successful integration of digital health apps into medical practice.

22 June 2023 in Patient Education and Counseling
Verified
Journal Article
Open access
TSTanja Schroeder
Tanja Schroeder
KSKarla Seaman
Karla Seaman
ANAmy Nguyen
Amy Nguyen
HGHeiko Gewald
Heiko Gewald
AGAndrew Georgiou
Andrew Georgiou
Germany is the first country that approved validated mobile health apps (called DiGA) for prescription by doctors and psychotherapists. The aim of this study is to investigate doctors' perspectives towards these mobile health apps and their intentions to prescribe them. Additionally, we investigated the influence of different roles and expectations of outcomes. We used a qualitative study design to determine doctors' viewpoints on prescribing DiGAs. We conducted 28 semi-structured interviews and used the grounded theory method for analysis. We adopted a classical conceptualist approach to gain theoretical insights. The results show that doctors' acceptance and support of DiGAs are critical in mobile health uptake and utilisation. Although mobile health is seen to be supportive of patient management and patient education doctors nevertheless need to adopt a motivating and persuasive role in the process. Doctors consider DiGAs complementary to their role in patient management and are predominantly positive about DiGAs. A trusted relationship with patients must be developed to ensure the appropriate support of DiGAs. Our study suggests that targeted education, user-centred DiGAs, consideration of social presence and user engagement, and co-development with doctors can improve longer-term DiGA use and effectiveness.

19 August 2025 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
SSSamantha Spanos
Samantha Spanos
SWShalini Wijekulasuriya
Shalini Wijekulasuriya
LELouise A. Ellis
Louise A. Ellis
MSMaree Saba
Maree Saba
TSTanja Schroeder
Tanja Schroeder
YZYvonne Zurynski
Yvonne Zurynski
Introduction: Social prescribing (SP) involves person-centred integration of non-clinical supports into care, which is critical for addressing mental health and psychosocial needs and enhancing wellbeing. This systematic review evaluated the impact of SP referral pathways on mental health, wellbeing, and psychosocial outcomes. Methods: Four databases (Medline, Embase, PsycINFO and Scopus) were searched for empirical studies of referral pathways to community-based SP interventions targeting mental health, psychosocial factors and/or wellbeing. Data from studies published from January 2010 to April 2024 were extracted; referral pathways, interventions, and their resultant outcomes were synthesised and tabulated. Results: Across the 30 included studies, 27 SP interventions and two main referral pathways were identified, involving providers across health, community, social, and voluntary care sectors. Quantitative outcomes (n = 21, 70%) most frequently measured were wellbeing, anxiety, depression and quality of life. Findings were mixed, and widely varying methodological approaches limited study comparability. Qualitative outcomes (n = 16, 53%) were mostly associated with social interactions (e.g., increased sense of belonging) and self-concepts and feelings (e.g., increased sense of purpose). Discussion and conclusion: Research on SP referral pathways supporting mental health, wellbeing and psychosocial outcomes is proliferating, but high heterogeneity in the evidence base limits conclusive inferences about effectiveness. Standardised quantitative measurement of core outcomes, supplemented by rigorous qualitative designs, will enhance capacity to demonstrate the value of an SP approach to integrated care for mental and psychosocial health and wellbeing.